Modafinil Australia: Understanding Modafinil Tablets and Available Products

For readers researching modafinil Australia, this category brings together nine products currently presented within the ModvigilAUS Modafinil category, alongside educational information about modafinil, recognised treatment contexts, Australian prescription status, safety considerations and the differences between an active pharmaceutical ingredient and individual finished products.

Modafinil is a wakefulness-promoting medicine used in clinical settings involving excessive daytime sleepiness associated with particular diagnosed sleep disorders. The products listed on this page are presented within the Modafinil category, but category placement alone should not be treated as independent proof of each finished product’s composition, Australian regulatory status, approved indications, bioequivalence or interchangeability.

If a healthcare professional has recommended a specific product or strength, review the relevant product-specific information rather than assuming that another brand or strength can be substituted.

Category Overview

The current category contains nine product destinations:

• One product presented at 100mg
• Seven products presented at 200mg
• One product presented at 400mg
• Educational resources for understanding modafinil products and safety
• Australian regulatory context for modafinil as a Schedule 4 medicine

The milligram value shown in a product name or listing describes the presented or labelled strength. It does not establish the appropriate prescribed dose for an individual, and a higher strength does not automatically mean a more effective or more suitable treatment.

In Australia, modafinil is a Schedule 4 Prescription Only Medicine. This ingredient-level scheduling status does not, by itself, establish ARTG registration or Australian-approved Product Information for every finished product listed in this category.

What Is Modafinil?

Modafinil is a prescription wakefulness-promoting medicine, sometimes described as a eugeroic. It has been studied and used in clinical contexts involving excessive daytime sleepiness rather than as a general-purpose energy, study or productivity aid.

Its pharmacological profile differs from conventional stimulant medicines, but that distinction should not be interpreted as meaning that modafinil is non-stimulating, inherently safer or clinically superior.

For broader educational context on the distinction between an active ingredient and a branded finished product, see Modvigil 200mg vs Modafinil.

Recognised Clinical Uses of Modafinil

Modafinil has recognised clinical uses in disorders associated with excessive sleepiness. Depending on the applicable clinical and registered-product evidence, these can include:

• Narcolepsy
• Shift work sleep disorder in appropriately selected patients
• Excessive daytime sleepiness associated with obstructive sleep apnoea as part of broader management

For obstructive sleep apnoea, wakefulness-promoting treatment addresses residual or persistent sleepiness. It does not correct the underlying airway obstruction and does not replace appropriate primary treatment such as CPAP where prescribed or recommended.

These are modafinil-level clinical contexts. They should not be read as proof that all nine products in this category have identical Australian-approved indications, Product Information or regulatory status.

Product choice also involves more than diagnosis alone. Relevant considerations can include labelled strength, formulation, product documentation, regulatory status, available evidence and the prescribing healthcare professional’s assessment.

How Modafinil Supports Wakefulness

The precise mechanism of modafinil is not fully understood. Research indicates that dopamine-related and other neural systems involved in wakefulness and sleep–wake regulation contribute to its pharmacological effects.

Proposed involvement of additional neurotransmitter systems should be interpreted cautiously rather than as a single, fully established causal pathway.

The effect of modafinil also needs to be considered in the context of the underlying disorder. Narcolepsy, shift work sleep disorder and obstructive sleep apnoea involve different clinical circumstances, so the role of wakefulness-promoting treatment is not identical in every condition.

Available Products in the Modafinil Category

The following nine products are currently presented within this category. Product links are retained so readers can review the information available for each finished product.

Modalert 100mg

Modalert 100mg is presented at a labelled strength of 100mg. Official Sun Pharma catalogue evidence has been identified for MODALERT 100 MG TABLET with modafinil, 100mg and tablet dosage form.

This product-specific information should not be extended into unsupported claims about Australian registration, identical formulation with another strength or automatic interchangeability.

Modalert 200mg

Modalert 200mg is presented at 200mg. Sun Pharma’s official product catalogue supports the Modalert product identity, modafinil as the listed ingredient, 200mg strength and tablet form.

The catalogue supports a Sun Pharma product association but should not be stretched into unsupported claims concerning a particular manufacturing site, Australian ARTG registration or Australian-approved indications.

Modvigil 200mg

Modvigil 200mg is presented within the category at a 200mg strength.

Readers should use the dedicated product page and applicable product-specific documentation for composition, company, formulation and regulatory details rather than assuming that evidence for MODAVIGIL, Modalert or another modafinil product applies to Modvigil.

Modawake 200mg

Modawake 200mg is presented at 200mg.

Product-specific company, composition and regulatory conclusions should be based on evidence applying to Modawake itself. A brand or company association does not automatically establish current manufacturing responsibility, manufacturing site or Australian approval.

Modafresh 200mg

Modafresh 200mg is presented at 200mg within this category.

Where sufficiently authoritative exact-product documentation is unavailable, readers should rely on the product-specific page and verifiable product documentation rather than transferring claims from another modafinil brand.

Modaheal 200mg

Modaheal 200mg is presented at 200mg.

No manufacturer, composition, dosage-form or regulatory claim should be inferred solely from its inclusion in the category. Review its dedicated page for product-specific information.

Modacharge 200mg

Modacharge 200mg is presented at 200mg.

Company, manufacturing, composition and Australian regulatory claims should be based on exact-product evidence rather than assumptions drawn from older product copy or another brand.

Vilafinil 200mg

Vilafinil 200mg is presented at 200mg.

Where available, exact product/company documentation may support specific product facts, but company association should not be overstated as proof of manufacturing arrangements, bioequivalence or Australian regulatory status.

Modasmart 400mg

Modasmart 400mg is the only product in this category presented at a 400mg strength.

A 400mg product listing does not establish that 400mg is an appropriate single dose, total daily dose or Australian-approved regimen. Higher milligram strength should never be interpreted as inherently more effective or appropriate.

Product Comparison Table

Product	Presented Strength	Active Ingredient	Company / Manufacturer Information	Dosage Form
Modalert 100mg	100mg	Modafinil — supported by official product catalogue evidence	Sun Pharma product association supported	Tablet — supported
Modalert 200mg	200mg	Modafinil — supported by official product catalogue evidence	Sun Pharma product association supported	Tablet — supported
Modvigil 200mg	200mg	See product-specific information	See product-specific information	See product-specific information
Modawake 200mg	200mg	See product-specific information	See product-specific information	See product-specific information
Modafresh 200mg	200mg	See product-specific information	See product-specific information	See product-specific information
Modaheal 200mg	200mg	See product-specific information	See product-specific information	See product-specific information
Modacharge 200mg	200mg	See product-specific information	See product-specific information	See product-specific information
Vilafinil 200mg	200mg	See product-specific information	See product-specific information	See product-specific information
Modasmart 400mg	400mg	See product-specific information	See product-specific information	See product-specific information

The table is provided for category navigation and evidence-aware comparison. A matching stated ingredient or strength does not establish identical formulation, bioequivalence, therapeutic equivalence, interchangeability, clinical performance or regulatory status.

For broader comparison-oriented reading, see the Best Modafinil Tablets Australia buyer’s guide.

How Finished Products Can Differ

Finished medicines presented within the same category can differ in more than brand name.

Potential differences can include:

• Labelled strength
• Formulation
• Excipients
• Dosage form and presentation
• Company or manufacturer information
• Product documentation
• Regulatory status
• Product Information
• Available clinical or quality evidence

A shared or claimed active ingredient should not be interpreted as proof that products are pharmaceutically identical, bioequivalent, therapeutically equivalent or interchangeable.

Formal generic status should also not be assumed unless the relevant regulatory and equivalence requirements have actually been established.

Understanding Available Strengths

The current category architecture consists of:

• One product presented at 100mg
• Seven products presented at 200mg
• One product presented at 400mg

These are product-listing strengths, not treatment recommendations.

The appropriate dose for an individual depends on clinical assessment and applicable product-specific information. No reader should self-select a product simply because it has a higher labelled strength.

Important Safety Considerations

Before modafinil treatment begins, patients should discuss their medical history and other medicines with an appropriately qualified healthcare professional.

Ingredient-level and authorised-product safety information makes cardiovascular disease, high blood pressure, liver disease, significant psychiatric history and other relevant health conditions important considerations during clinical assessment.

A history of substance misuse should also be discussed in neutral, non-stigmatising terms so the prescriber can assess overall treatment suitability.

Exact precautions, contraindications, monitoring recommendations and frequencies may differ between registered products and should not be assumed to be identical across every brand presented in this category.

Pregnancy

Pregnancy requires particular caution.

The TGA’s August 2025 Product Information safety update concerns the Australian registered modafinil product MODAVIGIL and strengthened pregnancy-related safety information for that product.

MODAVIGIL is not MODVIGIL, and its Product Information should not be treated as Product Information for Modvigil, Modalert, Modawake, Modafresh, Modaheal, Modacharge, Vilafinil or Modasmart.

Anyone who is pregnant, planning pregnancy or becomes pregnant while receiving modafinil should seek medical advice promptly.

Breastfeeding

Breastfeeding should be considered separately from the pregnancy-specific MODAVIGIL regulatory update. People who are breastfeeding or planning to breastfeed should discuss modafinil treatment with their healthcare professional.

Possible Side Effects

Modafinil can cause adverse effects. Reported effects in authoritative modafinil information include symptoms such as headache, nausea, dizziness, insomnia and other adverse reactions.

Exact frequency classifications should be taken from the applicable authoritative Product Information rather than assumed to be identical across every finished product listed here.

Serious reactions associated with modafinil can include severe skin reactions, serious hypersensitivity reactions, significant psychiatric symptoms and cardiovascular symptoms.

Seek prompt medical attention for serious or unexpected symptoms such as:

• A severe or spreading rash
• Facial or throat swelling
• Difficulty breathing
• Chest pain or significant cardiovascular symptoms
• Hallucinations
• Suicidal thoughts
• Marked changes in mood or behaviour

For broader safety education involving one separate branded product, see Modvigil 200mg side effects. That article should not be treated as universal Product Information for every product in this category.

Medicine Interactions

Modafinil can affect the metabolism or activity of some medicines.

Clinically relevant interaction considerations include hormonal or steroidal contraception, warfarin and certain medicines affected by relevant liver-enzyme pathways. The importance of an interaction depends on the specific medicine and the individual’s circumstances.

Modafinil can reduce the effectiveness of hormonal contraception. People using hormonal contraceptive methods should obtain individual advice from their healthcare professional or pharmacist rather than relying on a universal rule for every finished product.

Ingredient-level interaction potential may be relevant when a product actually contains modafinil, but exact product composition and Product Information must not be assumed solely from category placement.

Patients should provide their healthcare professional with a complete list of prescription medicines, over-the-counter products, vitamins, herbal products and supplements.

Responsible Use

Modafinil is Schedule 4 and prescription-only in Australia. This does not mean that every finished product in this category is individually ARTG registered or supported by Australian-approved Product Information.

Responsible use includes:

• Following the prescriber’s directions
• Not changing the prescribed dose independently
• Not switching between branded products without professional guidance
• Not sharing prescription medicines
• Maintaining healthy sleep habits and appropriate treatment of the underlying disorder

Products with similar names, strengths or claimed ingredients should not automatically be treated as interchangeable.

Storage Guidance

Follow the exact storage instructions printed on the supplied packaging or contained in valid product-specific information.

Storage requirements should not be assumed to be identical for all nine products.

Keep medicines out of sight and reach of children and do not use a medicine after the expiry date shown on its packaging. If storage conditions are unclear, ask a pharmacist.

Product Research for Australian Consumers

People researching modafinil Australia should separate medicine verification from general website or ecommerce service information.

Medicine and Product Verification

Useful checks can include:

• Exact product name
• Labelled strength
• Stated active ingredient where verifiable
• Dosage form
• Product-specific documentation
• Company or manufacturer information where supported
• Applicable regulatory status
• Batch and expiry information where supplied
• Whether the exact product and strength match the prescriber’s instructions

Manufacturer names and packaging can assist with product identification, but they do not independently prove authenticity, pharmaceutical quality, composition or ARTG registration.

Likewise, sealed packaging alone should not be treated as proof of authenticity.

Website and Service Information

Separate service considerations can include:

• Shipping information
• Refund or reship policies
• Customer-support accessibility
• Checkout and privacy information

These ecommerce features may help readers assess a supplier’s service processes, but they do not establish medicine quality or regulatory approval.

For site-specific information, review the Shipping Policy and Refund & Reship Policy.

Frequently Asked Questions

What is modafinil?

Modafinil is a prescription wakefulness-promoting medicine used in clinical settings involving excessive daytime sleepiness associated with certain diagnosed sleep disorders.

It should not be treated as a general-purpose study, productivity or lifestyle wakefulness aid.

What are modafinil tablets used for?

Modafinil has recognised clinical uses in contexts including narcolepsy, shift work sleep disorder and residual excessive sleepiness associated with obstructive sleep apnoea under appropriate management.

These ingredient-level treatment contexts do not mean that every branded product in this category has identical Australian-approved indications.

Is modafinil the same as Modalert, Modvigil or another brand?

No. Modafinil is the active pharmaceutical ingredient.

Modalert, Modvigil and the other named products on this page are finished branded products presented within the category. Exact composition and regulatory status should be established from product-specific evidence rather than assumed solely from category placement.

How can modafinil brands differ?

Finished products can differ in labelled strength, formulation, excipients, presentation, company or manufacturer information, regulatory status, Product Information and available supporting evidence.

Sharing a claimed ingredient does not prove bioequivalence, therapeutic equivalence or interchangeability.

What strengths are listed in this category?

The current nine-product inventory includes one product presented at 100mg, seven presented at 200mg and one presented at 400mg.

These figures describe listed product strengths, not recommended doses.

Does a higher strength work better?

Not necessarily.

A higher milligram strength does not automatically provide greater clinical benefit or make a product more appropriate for an individual. Dose and product selection require professional assessment.

Can modafinil replace normal sleep?

No. Modafinil may support wakefulness in appropriate clinical contexts, but it does not replace adequate sleep or treatment directed at the underlying sleep disorder.

What side effects can occur with modafinil?

Reported adverse effects can include headache, nausea, dizziness and insomnia, among others.

Frequency information should be taken from applicable authoritative Product Information rather than assumed to be identical across all finished products.

Can modafinil interact with other medicines?

Yes. Modafinil can interact with other medicines, including hormonal contraception, warfarin and medicines affected by relevant drug-metabolism pathways.

A healthcare professional or pharmacist should review the individual’s complete medicine list.

Can modafinil affect hormonal contraception?

Yes. Modafinil can reduce the effectiveness of hormonal contraception.

People using hormonal contraception should obtain individual contraceptive advice from an appropriately qualified healthcare professional.

How should modafinil products be stored?

Follow the exact storage conditions on the supplied product packaging or valid product-specific information.

Do not assume every brand in the category has identical storage requirements.

Is medical supervision required in Australia?

Yes. Modafinil is a Schedule 4 Prescription Only Medicine in Australia and requires appropriate professional assessment and prescribing.

That scheduling classification does not itself establish ARTG registration for every finished product listed in this category.

What should Australian readers check when researching a product?

Check the exact product name, labelled strength, product-specific documentation, regulatory information and whether the product matches the prescriber’s instructions.

Shipping, returns, support and website policies are separate service considerations and should not be treated as proof of medicine authenticity or quality.

Medical Disclaimer

The information on this modafinil Australia category page is provided for general educational purposes only and does not replace personalised medical advice, diagnosis or treatment. It should not be used to self-diagnose, self-select a medicine or strength, or substitute one branded product for another without professional guidance.

Modafinil is a Schedule 4 Prescription Only Medicine in Australia. Ingredient-level clinical, safety and scheduling information does not establish ARTG registration, Australian-approved indications, dosing, Product Information, bioequivalence or interchangeability for every named finished product listed on this page.

Australian regulatory or Product Information evidence for MODAVIGIL applies to MODAVIGIL and should not automatically be transferred to MODVIGIL or any other product in this category.

Treatment and product decisions should be made with an appropriately qualified healthcare professional.